Markowitz Wayne's Form 4 filing
Edwards Lifesciences Corp (EW) · filed May 11, 2026
- Accession no.
- 0001225208-26-005132
- Filed
- May 11, 2026
- Trade date
- May 7-11, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $47.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Markowitz WayneCIK 0001991414 | Officer (CVP, JAPAC) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | Common Stock | AGrant or awardAcquired | +5,200 | $0.00 | $0 | 22,762.87 | Direct | |
| May 7, 2026 | Common Stock | FTax withholdingDisposed | −264 | $83.20 | −$21,964.8 | 22,498.87 | Direct | |
| May 8, 2026 | Common Stock | FTax withholdingDisposed | −226 | $82.76 | −$18,703.76 | 22,272.87 | Direct | |
| May 11, 2026 | Common Stock | SSaleDisposed | −593 | $79.73 | −$47,279.89 | 21,679.87 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | Common Stock | AGrant or awardAcquired | +26,400 | $0.00 | $0 | 26,400 | Direct | |
| May 7, 2026 | Common Stock | AGrant or awardAcquired | +5,200 | $0.00 | $0 | 5,200 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.